Patents by Inventor Steven H. Fischer

Steven H. Fischer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Multiplex hybridization system for identification of pathogenic and method of use
    Patent number: 7271781
    Abstract: A method for species-specific identification of a Mycobacterium species is provided. Also disclosed is a method for identifying the species of Mycobacterium present in a sample. A device is disclosed for the detection of Mycobacterium. Mycobacterium-specific oligonucleotides are also disclosed, as are kits.
    Type: Grant
    Filed: March 1, 2001
    Date of Patent: September 18, 2007
    Assignees: The United States of America as Represented by the Secretary of the Department of Health and Human Services, Beckman Coulter, Inc.
    Inventors: Steven H. Fischer, Jang B. Rampal, Gary A. Fahle, Patricia S. Conville
  • Multiplex hybridization system for identification of pathogenic mycobacterium and method of use
    Publication number: 20040110129
    Abstract: A method for species-specific identification of a Mycobacterium species is provided. Also disclosed is a method for identifying the species of Mycobacterium present in a sample. A device is disclosed for the detection of Mycobacterium.Mycobacterium-specific oligonucleotides are also disclosed, as are kits.
    Type: Application
    Filed: August 27, 2002
    Publication date: June 10, 2004
    Inventors: Steven H Fischer, Jang B Rampal, Gary A Fable, Patricia S Conville
  • Identification of a region of the major surface glycoprotein (MSG) gene of human Pneumocystis carinii
    Publication number: 20040043409
    Abstract: Particularly sensitive techniques for the detection of P. carinii in clinical samples are disclosed. These techniques relate to the PCR amplification and/or detection of human-P. carinii major surface glycoprotein (MSG) gene sequences. Also disclosed are seven novel genes encoding human-P. carinii MSG, and the proteins encoded for by these genes. These genes provide proof that human-P. carinii MSG is encoded for by a highly conserved gene family, and that the corresponding proteins have a very highly conserved region of about 100 amino acids near their C-terminal end. This highly conserved carboxy-terminal region has a significantly different sequence than that found in rat-derived MSG.
    Type: Application
    Filed: September 2, 2003
    Publication date: March 4, 2004
    Applicant: The Government of the USA represented by Secretary of the Department of Health & Human Services
    Inventors: Joseph A. Kovacs, Shengning Huang, Henry Masur, Steven H. Fischer, Vee J. Gill, Qin Mei
  • Identification of a region of the major surface glycoprotein (MSG) gene of human Pneumocystis carinii
    Patent number: 6664053
    Abstract: Particularly sensitive techniques for the detection of P. carinii in clinical samples are disclosed. These techniques relate to the PCR amplification and/or detection of human-P. carinii major surface glycoprotein (MSG) gene sequences. Also disclosed are seven novel genes encoding human-P. carinii MSG, and the proteins encoded for by these genes. These genes provide proof that human-P. carinii MSG is encoded for by a highly conserved gene family, and that the conesponding proteins have a very highly conserved region of about 100 amino acids near their C-terminal end. This highly conserved carboxy-terminal region has a significantly different sequence than that found in rat-derived MSG.
    Type: Grant
    Filed: February 9, 2001
    Date of Patent: December 16, 2003
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Joseph A. Kovacs, Shengning Huang, Henry Masur, Steven H. Fischer, Vee J. Gill, Qin Mei